Skip to main contentSkip to navigation
Sirius Investors
Abcam plc

Abcam plc

ABCM
NASDAQHealthcare

Abcam plc (ABCM) Investment Research Dashboard

About Abcam plc (ABCM) stock analysis

Get live ABCM stock price $23.99, comprehensive Abcam plc stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time ABCM stock data and investment insights.

23.99
0.04%Today
Market Cap
5.52B
Volume
7.43M
52W High
25.32
52W Low
12.48

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Abcam plc operates as a prominent life science enterprise, dedicated to the innovation, creation, and supply of crucial reagents and instruments. These fundamental resources are instrumental in supporting diverse scientific investigations, diagnostic...

Company Information

CEO
Alan Thomas Hirzel BS,
Sector
Healthcare
Industry
Biotechnology
Employees
1760

Contact Information

Address
Discovery Drive
Country
GB

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 2399.0)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Abcam plc shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Abcam plc
  • Investors should consider how Abcam plc fits within their overall portfolio allocation
  • Premium valuation (P/E: 2399.0) requires strong growth to justify

Market Cap

5.52B

P/E Ratio (TTM)

2399.00

Beta

0.86

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

94/100 ⭐⭐⭐⭐⭐

Overall
+2.2%
NYSE
+1.9%
NASDAQ
+2.4%
Sector1D1W1MP/EScore
Healthcare+2.2%+2.5%+5.1%24.2
94/100⭐⭐⭐⭐⭐
Energy-0.5%+1.9%+3.1%19.1
86/100⭐⭐⭐⭐⭐
Communication Services+1.2%+0.9%+2.2%21.4
70/100⭐⭐⭐⭐⭐
Consumer Defensive+0.4%+0.1%+2.3%29.0
64/100⭐⭐⭐⭐
Financial Services-0.5%-2.2%+2.3%19.4
56/100⭐⭐⭐⭐
Consumer Cyclical+1.7%+0.5%-0.0%47.4
43/100⭐⭐⭐
Basic Materials+0.1%-1.4%-1.0%24.9
41/100⭐⭐⭐
Industrials-1.9%-1.8%+1.0%30.4
35/100⭐⭐
Real Estate+0.0%+0.2%-3.3%30.0
29/100⭐⭐
Technology-1.4%-2.0%-3.2%42.2
17/100
Utilities-0.2%-2.6%-9.3%26.6
13/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-08-20.